Type One Diabetes Completed Phase 4 Trials for Insulin glulisine (DB01309)

Back to Type One Diabetes

Also known as: Diabetes Mellitus, Juvenile-Onset / T1DM - Type 1 Diabetes Mellitus / Diabetes Type I / Type I Diabetes / Type1 Diabetes / Diabetes Type One / Diabete Type 1 / Type One Diabetes Mellitus / Diabetics Mellitus Type 1 / Type 1 Diabetes / Type 1 Diabetes Mellitus (T1DM) / Insulin-Dependent Diabetes Mellitus 1 / Type1diabetes / Diabetes Mellitus Type I / Type1 Diabetes Mellitus / Type 1 Diabetes (T1D) / Diabetes Mellitus Type 1 / Juvenile Onset Diabetes Mellitus / Diabetes Type 1 / Type 1 Insulin-Dependent Diabetes Mellitus / Type I Diabetes Mellitus / Diabetes Mellitus, Sudden-Onset / Type-1 Diabetes Mellitus / Insulin Dependent Diabetes Mellitus 1 / Type 1 Diabetes Mellitus / Juvenile-Onset Diabetes / Diabetes Mellitus, Insulin-Dependent, 1 / Diabetes mellitus type 1 (disorder) / Diabetes mellitus: [juvenile] or [insulin dependent] / Juvenile diabetes / Insulin dependent diabetic / IDDM / Diabetes mellitus insulin-dependent / Insulin-dependent diabetes mellitus / Diabetes mellitus juvenile onset / Immune-mediated diabetes / Insulin dependent diabetes mellitus / Insulin dependent diabetes mel / IDDM - Insulin-dependent diabetes mellitus / Diabetes mellitus - juvenile / Ketosis-prone diabetes mellitus (disorder) / Ketosis-prone diabetes mellitus

Indication	Status	Phase
DBCOND0076728 (Type One Diabetes)	Completed	4

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02914886	Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)	Treatment	Glulisine (DB31448) Insulin glulisine (DB01309) Insulin human (DB00030)
NCT02276859	Normal Versus Dual Wave Insulin Bolus for High-protein Food	Treatment	Insulin aspart (DB01306) Insulin glulisine (DB01309) Insulin lispro (DB00046)
NCT04019821	Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal	Treatment	Insulin aspart (DB01306) Insulin glulisine (DB01309) Insulin lispro (DB00046)
NCT00964574	Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes Mellitus	Treatment	Insulin glargine (DB00047) Insulin glulisine (DB01309)
NCT03328845	Impact on the Oxidative Stress of the Different Analogues of Insulin in People With Type 1 Diabetes. (Ineox Study)	Treatment	Glulisine (DB31448) Insulin aspart (DB01306) Insulin degludec (DB09564) Insulin glargine (DB00047) Insulin glulisine (DB01309) Insulin human (DB00030) Insulin lispro (DB00046)
NCT00913497	The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children	Treatment	Insulin aspart (DB01306) Insulin glulisine (DB01309)
NCT00607087	Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus	Treatment	Insulin aspart (DB01306) Insulin glulisine (DB01309) Insulin lispro (DB00046)
NCT01204593	baSal BoluS Therapy in patIenTs With TypE 1 Diabetes Mellitus	Treatment	Insulin glargine (DB00047) Insulin glulisine (DB01309)
NCT01678235	Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus	Treatment	Insulin aspart (DB01306) Insulin glulisine (DB01309)
NCT00539448	Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study	Treatment	Insulin glargine (DB00047) Insulin glulisine (DB01309)
NCT01202474	Apidra Children & Adolescents Study	Treatment	Insulin glargine (DB00047) Insulin glulisine (DB01309)
NCT00489190	APIDRA Registration Study	Treatment	Insulin glulisine (DB01309)
NCT01848990	CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)	Treatment	Glulisine (DB31448) Hyaluronidase (human recombinant) (DB06205) Insulin aspart (DB01306) Insulin glulisine (DB01309) Insulin lispro (DB00046)
NCT04124302	The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.	Treatment	Insulin aspart (DB01306) Insulin glulisine (DB01309) Insulin lispro (DB00046)